Background <p>Acute diarrhoea or soft stools can occur in kittens after environmental challenges. The effects of a probiotic on gastrointestinal and immune biomarkers in kittens exposed to three study events were investigated. Healthy weaned 10-week-old kittens were fed a daily dietary supplement of <i>Saccharomyces cerevisiae</i> var. <i>boulardii</i> CNCM I-1079 (SB-1079) or placebo for 7 weeks (20 kittens/group). The study events were a routine booster vaccination (Week 3), a change in housing (Week 5), and a diet transition (Week 6). Outcomes included faecal scores and percentage dry matter (DM%), total serum IgG, faecal IgA, and faecal microbiota. Statistical analyses included Linear Mixed Models and Generalized Linear Mixed Models with group, time and group × time interaction as fixed effects; longitudinal Kruskal-Wallis test corrected for false discovery rate was used for microbiota outcomes.</p> Results <p>Faecal scores were optimal throughout the whole study for 12/20 supplemented kittens vs 8/20 control kittens. Overall, group and group × time did not affect faecal quality or moisture, but in Week 5 (housing change) supplemented kittens had firmer stools (<i>P</i>=0.007) and lower faecal DM% (<i>P</i>=0.032) than placebo kittens. Total serum IgG concentration was affected by group (<i>P</i>=0.028), time (<i>P</i>&lt;0.001) and group × time (<i>P</i>=0.001), and was higher in the probiotic vs placebo group (<i>P</i>&lt;0.039) at Week 7, having increased 250% vs 62% from Week 0. Faecal IgA concentration tended to be higher in the probiotic vs placebo group after booster vaccination (<i>P</i>=0.068). Microbiota composition (weighted Unifrac beta diversity) differed between groups overall (<i>P</i>=0.025), at Week 4 (<i>P</i>=0.017), and in the differences between Week 6 and 7 (<i>P</i>=0.008). In supplemented kittens, relative abundances of Veillonellaceae and Actinobacteria remained stable over the first weeks, and abundance of potential pathogens in the Desulfovibrionaceae family decreased. A decrease in Shannon alpha diversity of faecal microbiota post diet transition was significant in supplemented kittens only (<i>P</i> = 0.008) due to a rapid increase in abundance of the Helicobacteraceae family. </p> Conclusions <p>The impacts of SB-1079 on biomarkers of gastrointestinal and immunological health suggest its potential to promote resilience of these systems in young kittens experiencing physiological challenges like new environments and diet transitions.</p> Clinical trial number <p>Not applicable.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A placebo-controlled study of the effects of Saccharomyces cerevisiae var. boulardii CNCM I-1079 probiotic on faecal quality, microbiota and immunity in weaned kittens

  • Virginie Gaillard,
  • Ana Rodiles,
  • Amélie Mugnier,
  • Jérémy Laxalde,
  • Diana Knight,
  • Willy Joly,
  • Franck Péron

摘要

Background

Acute diarrhoea or soft stools can occur in kittens after environmental challenges. The effects of a probiotic on gastrointestinal and immune biomarkers in kittens exposed to three study events were investigated. Healthy weaned 10-week-old kittens were fed a daily dietary supplement of Saccharomyces cerevisiae var. boulardii CNCM I-1079 (SB-1079) or placebo for 7 weeks (20 kittens/group). The study events were a routine booster vaccination (Week 3), a change in housing (Week 5), and a diet transition (Week 6). Outcomes included faecal scores and percentage dry matter (DM%), total serum IgG, faecal IgA, and faecal microbiota. Statistical analyses included Linear Mixed Models and Generalized Linear Mixed Models with group, time and group × time interaction as fixed effects; longitudinal Kruskal-Wallis test corrected for false discovery rate was used for microbiota outcomes.

Results

Faecal scores were optimal throughout the whole study for 12/20 supplemented kittens vs 8/20 control kittens. Overall, group and group × time did not affect faecal quality or moisture, but in Week 5 (housing change) supplemented kittens had firmer stools (P=0.007) and lower faecal DM% (P=0.032) than placebo kittens. Total serum IgG concentration was affected by group (P=0.028), time (P<0.001) and group × time (P=0.001), and was higher in the probiotic vs placebo group (P<0.039) at Week 7, having increased 250% vs 62% from Week 0. Faecal IgA concentration tended to be higher in the probiotic vs placebo group after booster vaccination (P=0.068). Microbiota composition (weighted Unifrac beta diversity) differed between groups overall (P=0.025), at Week 4 (P=0.017), and in the differences between Week 6 and 7 (P=0.008). In supplemented kittens, relative abundances of Veillonellaceae and Actinobacteria remained stable over the first weeks, and abundance of potential pathogens in the Desulfovibrionaceae family decreased. A decrease in Shannon alpha diversity of faecal microbiota post diet transition was significant in supplemented kittens only (P = 0.008) due to a rapid increase in abundance of the Helicobacteraceae family.

Conclusions

The impacts of SB-1079 on biomarkers of gastrointestinal and immunological health suggest its potential to promote resilience of these systems in young kittens experiencing physiological challenges like new environments and diet transitions.

Clinical trial number

Not applicable.